⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for salivary gland cancers

Every month we try and update this database with for salivary gland cancers cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)NCT02568267
Breast Cancer
Cholangiocarcin...
Colorectal Canc...
Head and Neck N...
Lymphoma, Large...
Melanoma
Neuroendocrine ...
Non-Small Cell ...
Ovarian Cancer
Pancreatic Canc...
Papillary Thyro...
Primary Brain T...
Renal Cell Carc...
Sarcomas
Salivary Gland ...
Adult Solid Tum...
Entrectinib
18 Years - Hoffmann-La Roche
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsNCT04644315
Neoplasms
Colorectal Neop...
Melanoma
Pancreatic Neop...
Sarcoma
Ovarian Neoplas...
Brain Neoplasms
Thyroid Neoplas...
Neuroendocrine ...
Cholangiocarcin...
Salivary Gland ...
Head and Neck N...
Thyroid Cancer,...
Lymphoma, Large...
Neoplasms by Si...
Respiratory Tra...
Thoracic Neopla...
Respiratory Tra...
Carcinoma, Bron...
Bronchial Neopl...
Intestinal Neop...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Gastrointestina...
Colonic Disease...
Intestinal Dise...
Central Nervous...
Alectinib
18 Years - Hoffmann-La Roche
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland CancersNCT05884320
Gland
Salivary Gland ...
Sacituzumab Gov...
18 Years - M.D. Anderson Cancer Center
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsNCT04644315
Neoplasms
Colorectal Neop...
Melanoma
Pancreatic Neop...
Sarcoma
Ovarian Neoplas...
Brain Neoplasms
Thyroid Neoplas...
Neuroendocrine ...
Cholangiocarcin...
Salivary Gland ...
Head and Neck N...
Thyroid Cancer,...
Lymphoma, Large...
Neoplasms by Si...
Respiratory Tra...
Thoracic Neopla...
Respiratory Tra...
Carcinoma, Bron...
Bronchial Neopl...
Intestinal Neop...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Gastrointestina...
Colonic Disease...
Intestinal Dise...
Central Nervous...
Alectinib
18 Years - Hoffmann-La Roche
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsNCT01678105
Recurrent Adeno...
Metastatic Aden...
Salivary Gland ...
ACC
Dovitinib
18 Years - Ontario Clinical Oncology Group (OCOG)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: